Market intelligence
NKTRHealthcare
Nektar Therapeutics insider activity
In the last 90 days, no corporate insiders reported open-market purchases.
SEC-reported filing activity is provided for research purposes and is not investment advice.
- 90-day C-suite buyers
- 0
- 90-day purchase value
- $0.00
- Corporate buyers
- 0
- Latest transaction
- Jun 17, 2026
Executive filings
Open-market transaction history
Purchase and sale summaries are ordered by the latest reported transaction date.
